UK markets closed

TheraVet SA (ALVET.PA)

Paris - Paris Delayed price. Currency in EUR
Add to watchlist
5.24-0.02 (-0.38%)
At close: 05:25PM CET
Currency in EUR

Valuation measures4

Market cap (intra-day) 20.57M
Enterprise value 14.46M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)12.16
Price/book (mrq)2.08
Enterprise value/revenue 8.55
Enterprise value/EBITDA -24.17

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-35.06%
S&P500 52-week change 316.27%
52-week high 38.56
52-week low 35.22
50-day moving average 35.93
200-day moving average 36.47

Share statistics

Avg vol (3-month) 32.21k
Avg vol (10-day) 32.87k
Shares outstanding 53.22M
Implied shares outstanding 6N/A
Float 8N/A
% held by insiders 1N/A
% held by institutions 1N/A
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2019
Most-recent quarter (mrq)30 Jun 2021

Profitability

Profit margin -42.54%
Operating margin (ttm)-40.99%

Management effectiveness

Return on assets (ttm)-3.19%
Return on equity (ttm)-6.85%

Income statement

Revenue (ttm)232.54k
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)225.70%
Gross profit (ttm)232.54k
EBITDA -88.84k
Net income avi to common (ttm)-98.93k
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)7.25M
Total cash per share (mrq)2.25
Total debt (mrq)796.59k
Total debt/equity (mrq)8.04
Current ratio (mrq)2.87
Book value per share (mrq)3.07

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A